ARTICLE | Financial News
SymBio financial update
January 19, 2015 8:00 AM UTC
SymBio Pharmaceuticals Ltd. (JASDAQ:4582), Tokyo, Japan Business: Cancer, Hematology, Autoimmune Date announced: 2015-01-13 Note: SymBio is establishing a level I ADR program on the OTC market. Each A...